Y-3 for Injection
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants (NCT07068841) | Neurodawn Pharmaceutical Co., Ltd. | 2025-05-18 |
Track Y-3 for Injection automatically
Every clearance here is in the API, with alerts when new ones post.